The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 30, 2012

Filed:

Oct. 11, 2010
Applicants:

Hui LI, Santa Clara, CA (US);

Vanessa Taylor, San Francisco, CA (US);

Somasekhar Bhamidipati, Foster City, CA (US);

John Ramphal, Union City, CA (US);

Kin Tso, San Francisco, CA (US);

Arvinder Sran, Fremont, CA (US);

Holger Keim, Irvine, CA (US);

Vadim Markovtsov, San Mateo, CA (US);

David Carroll, San Francisco, CA (US);

Sambaiah Thota, Fremont, CA (US);

Ankush Argade, Foster City, CA (US);

Jeffrey Wayne Clough, Redwood City, CA (US);

Rajinder Singh, Belmont, CA (US);

Robin Cooper, St. George Island, FL (US);

Inventors:

Hui Li, Santa Clara, CA (US);

Vanessa Taylor, San Francisco, CA (US);

Somasekhar Bhamidipati, Foster City, CA (US);

John Ramphal, Union City, CA (US);

Kin Tso, San Francisco, CA (US);

Arvinder Sran, Fremont, CA (US);

Holger Keim, Irvine, CA (US);

Vadim Markovtsov, San Mateo, CA (US);

David Carroll, San Francisco, CA (US);

Sambaiah Thota, Fremont, CA (US);

Ankush Argade, Foster City, CA (US);

Jeffrey Wayne Clough, Redwood City, CA (US);

Rajinder Singh, Belmont, CA (US);

Robin Cooper, St. George Island, FL (US);

Assignee:

Rigel Pharmaceuticals, Inc., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/505 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.


Find Patent Forward Citations

Loading…